Haematology

Cancer services

We provide a full range of services for the diagnosis and management of patients with all types of blood disorders, including cancers of the blood.

Attend Anywhere video consultation

Did you know your outpatient appointment for this service may now be done by video consultation using Attend Anywhere. This enables you to be able to attend your appointment from home, saving you time and money.

Find out more about outpatient video appointments

We have close links to the University of Cambridge, and are internationally renowned for our clinical expertise, laboratory diagnostic work and scientific research into the understanding and treatment of blood disorders. We are extensively involved in undergraduate and postgraduate training.

Recently, the Cambridge Cellular Therapy Laboratory (CCTL) team have joined our cancer directorate. CCTL is a vital part of the bone marrow transplant service here (they also provide a service to Ipswich hospital and Norfolk & Norwich Hospital). CCTL offers the assessment, processing and storage of cells collected from bone marrow and peripheral blood intended for autologous or allogeneic transplant.

In addition, non-malignant Haematology including Haemophilia, Thrombophilia and Thrombosis services have also joined our cancer directorate.

The Haemophilia and Thrombophilia centre specialises in the diagnosis and management of people with inherited and acquired bleeding disorders, the investigation and management of people with inherited and acquired disorders that predispose them to thrombosis and the management of individuals on a wide variety of anticoagulants.                                                                                              T

The Thrombosis service is a team of specialist nurses who provide a fast track deep vein thrombosis (DVT) assessment service. They also run a daily clinic to facilitate the early discharge of patients with DVT and pulmonary embolism (PE).

CUH (comprising of the Haematology/ Apheresis teams and the Cambridge Cellular Therapy Laboratory) has been selected by NHS England to be one of 10 CAR-T Chimeric Antigen Receptors Cell Therapy centres in the UK.

CAR-T is a highly complex and innovative new treatment. CAR-T is a type of immunotherapy which involves collecting and using the patients’ own immune cells to treat their condition.

What do we do

We provide a full range of services for the diagnosis and management of patients with all types of blood disorders, including cancers of the blood.

The Centre includes the East Anglia Blood and Marrow Transplant Unit which provides a comprehensive service for the treatment of cancer. We offer high-dose therapy with bone marrow and peripheral blood stem-cell support, plus a dedicated outpatient department with day-case facilities for the treatment of patients undergoing transfusion, chemotherapy and apheresis.

Recently, the Cambridge Cellular Therapy Laboratory (CCTL) team have joined our cancer directorate. CCTL is a vital part of the bone marrow transplant service here (they also provide a service to Ipswich hospital and Norfolk & Norwich Hospital). CCTL offers the assessment, processing and storage of cells collected from bone marrow and peripheral blood intended for autologous or allogeneic transplant.

In addition, non-malignant Haematology including Haemophilia, Thrombophilia and Thrombosis services have also joined our cancer directorate.

The Haemophilia and Thrombophilia centre specialises in the diagnosis and management of people with inherited and acquired bleeding disorders, the investigation and management of people with inherited and acquired disorders that predispose them to thrombosis and the management of individuals on a wide variety of anticoagulants.                                                                                              T

The Thrombosis service is a team of specialist nurses who provide a fast track deep vein thrombosis (DVT) assessment service. They also run a daily clinic to facilitate the early discharge of patients with DVT and pulmonary embolism (PE).

CUH (comprising of the Haematology/ Apheresis teams and the Cambridge Cellular Therapy Laboratory) has been selected by NHS England to be one of 10 CAR-T Chimeric Antigen Receptors Cell Therapy centres in the UK.

CAR-T is a highly complex and innovative new treatment. CAR-T is a type of immunotherapy which involves collecting and using the patients’ own immune cells to treat their condition. 

Outpatients

The Haematology day unit is where patients receive their care on an outpatient basis.

Where to find us

The Haematology Day Unit can be found opposite the main hospital entrance. Approach the main entrance, but do not enter and instead follow round to the right - the entrance to the unit is in the corner (opposite the main entrance).